Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus, and will pursue opportunities to address other serious virus-associated disease.